Article Text

other Versions

PDF
Original research article
Cardiopulmonary fitness in children with congenital heart diseases versus healthy children
  1. Pascal Amedro1,2,3,4,
  2. Arthur Gavotto1,3,
  3. Sophie Guillaumont1,3,5,
  4. Helena Bertet6,7,
  5. Marie Vincenti1,2,3,5,
  6. Gregoire De La Villeon1,3,5,
  7. Charlène Bredy1,3,5,
  8. Philippe Acar8,
  9. Caroline Ovaert9,10,
  10. Marie-Christine Picot6,7,
  11. Stefan Matecki2,3
  1. 1Paediatric and Adult Congenital Cardiology Department, M3C Regional Reference CHD Centre, University Hospital, Montpellier, France
  2. 2Physiology and Experimental Biology of Heart and Muscles Laboratory - PHYMEDEXP, UMR CNRS 9214 - INSERM U1046, University of Montpellier, Montpellier, France
  3. 3Physiology Department, Paediatric Functional Exploration Laboratory, University Hospital, Montpellier, France
  4. 4Self-perceived Health Assessment Research Unit - EA 3279 - Public Health Department, University of Aix-Marseille, Marseille, France
  5. 5Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute, Palavas-Les-Flots, France
  6. 6Epidemiology and Clinical Research Department, University Hospital, Montpellier, France
  7. 7Clinical Investigation Centre, INSERM U1411, Montpellier University Hospital, University of Montpellier, Montpellier, France
  8. 8Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Toulouse University Hospital, Toulouse, France
  9. 9Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, La Timone University Hospital, Marseille, France
  10. 10INSERM UMR S910, Medical Genetic Laboratory, University of Aix-Marseille, Marseille, France
  1. Correspondence to Dr Pascal Amedro, Paediatric and Adult Congenital Cardiology Department, MontpellierUniversity Hospital, Montpellier 34295, France; p-amedro{at}chu-montpellier.fr

Abstract

Objective We aimed to compare the cardiopulmonary fitness of children with congenital heart diseases (CHD) with that of age-adjusted and gender-adjusted controls. We also intended to identify clinical characteristics associated with maximum oxygen uptake (VO2max) in this population.

Methods and results We included in a cross-sectional multicentre study a total of 798 children (496 CHD and 302 controls) who underwent a complete cardiopulmonary exercise test (CPET). The association of clinical characteristics with VO2max was studied using a multivariate analysis. Mean VO2max in the CHD group and control represented 93%±20% and 107%±17% of predicted values, respectively. VO2max was significantly lower in the CHD group, overall (37.8±0.3vs 42.6±0.4 mL/kg/min, P<0.0001) and for each group (P<0.05). The mean VO2max decline per year was significantly higher in CHD than in the controls overall (−0.84±0.10 vs −0.19±0.14 mL/kg/min/year, P<0.01), for boys (−0.72±0.14vs 0.11±0.19 mL/kg/min/year, P<0.01) and for girls (−1.00±0.13 vs −0.55±0.21 mL/kg/min/year, P=0.05). VO2max was associated with body mass index, ventilatory anaerobic threshold, female gender, restrictive ventilatory disorder, right ventricle systolic hypertension, tricuspid regurgitation, the number of cardiac catheter or surgery procedures, and the presence of a genetic anomaly.

Conclusions Although the magnitude of the difference was not large, VO2max among children with CHD was significantly lower than in normal children. We suggest performing CPET in routine follow-up of these patients.

Trial registration number ClinicalTrials.gov NCT01202916;Post-results.

  • congenital heart disease
  • cardiac rehabilitation

Statistics from Altmetric.com

Footnotes

  • Contributors Study concept and design: PA, M-CP, SM. Acquisition, analysis or interpretation of data: PA, AG, HB, MV, SG, CB, GDLV, CO, PhA, M-CP, SM. Drafting of the manuscript: PA, M-CP, AG, HB. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: M-CP, HB. Obtained funding: PA. Administrative, technical or material support: PA, AG. Study supervision: PA, AG, MC-P, SM.

  • Funding Montpellier University Hospital Clinical Research Program (PHRC 8422) funded this study.

  • Competing interests None declared.

  • Ethics approval The South Mediterranean IV Ethics Committee, Montpellier, France, approved the study on 7 July 2009 (reference number 2009-A00423-54).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.